ZIM Laboratories has invested Rs 68.25 lakh which is AUD 1,23,525 (Australian Dollars) in the equity shares of ZIMTAS, out of the approved investment amount of up to Rs 2 crore. Post investment, the company holds 99.93% of the total share capital of ZIMTAS.
Earlier, the company’s board had approved investment of upto Rs 2 crore in equity shares of ZIMTAS, subsidiary of the company. The Investment is with an objective of Business Development in Australian and New Zealand markets.
ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develops generic pharmaceutical products.
